关键词: 恶唑烷酮类, 康替唑胺, 抗结核药, 治疗应用, 总结性报告(主题)

Abstract:

Contezolid, a novel generation of oxazolidinone antibiotics independently developed in China, has been approved for the treatment of complex skin and soft tissue infections. With its expanding exploratory applications in the clinical management of tuberculosis and the ongoing growth of related clinical research, there is an increasing demand among clinicians for comprehensive guidelines and standardized protocols for its use. To address this need, the Editorial Board of the Chinese Journal of Antituberculosis and the Chinese Antituberculosis Association convened experts nationwide for in-depth discussions, culminating in the development of the Expert consensus on the treatment of tuberculosis with contezolid. This consensus aims to standardize and guide healthcare professionals in the use of contezolid for tuberculosis treatment, addressing uncertainties arising from the lack of specified indications, dosages, or treatment durations in current drug labels and existing antituberculosis guidelines. It is hoped that this consensus will serve as a valuable reference for practitioners in China and contribute to the rational and effective application of contezolid in clinical practice.

Key words: Oxazolidinones, Contezolid, Antitubercular agents, Therapeutic applications, Consensus guidelines